Financial reports
Current reports
8-K
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
13 May 24
8-K
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
1 Apr 24
8-K
Regulation FD Disclosure
1 Apr 24
8-K
Amendments to Articles of Incorporation or Bylaws
6 Feb 24
Registration and prospectus
S-8
Registration of securities for employees
6 Feb 24
424B4
Prospectus supplement with pricing info
2 Feb 24
8-A12B
Registration of securities on exchange
29 Jan 24
S-1/A
IPO registration (amended)
29 Jan 24
S-1
IPO registration
14 Dec 23
DRS/A
Draft registration statement (amended)
21 Sep 23
DRS/A
Draft registration statement (amended)
22 Aug 23
D
$20.08M in debt, sold $20.08M, 4 investors
25 Jan 22
D
$100M in equity, sold $100M, 15 investors
22 Jun 21
D
$44.75M in equity, sold $44.75M, 15 investors
19 Mar 20
Proxies
No filings
Other
EFFECT
Notice of effectiveness
2 Feb 24
CERT
Certification of approval for exchange listing
1 Feb 24
SEC STAFF
SEC staff action: Order
1 Feb 24
CORRESP
Correspondence with SEC
30 Jan 24
CORRESP
Correspondence with SEC
30 Jan 24
CORRESP
Correspondence with SEC
29 Jan 24
UPLOAD
Letter from SEC
20 Dec 23
SEC STAFF
SEC staff action: Order
19 Dec 23
CORRESP
Correspondence with SEC
14 Dec 23
UPLOAD
Letter from SEC
3 Oct 23
Ownership
3/A
Harith Rajagopalan
14 May 24
4
Adrian Kimber
2 Apr 24
3
Adrian Kimber
2 Apr 24
SC 13G
General Catalyst GP V, LLC
16 Feb 24
SC 13G
CVF, LLC
14 Feb 24
4
Change in insider ownership
8 Feb 24
4
Change in insider ownership
8 Feb 24
4
Change in insider ownership
8 Feb 24
4
Change in insider ownership
8 Feb 24
4
CLIVE MEANWELL
8 Feb 24